To clarify the cell type that expresses Cnr2 during AD progression, we measured the mRNA levels of Cnr2 using isolated microglia and astrocytes in the cerebral cortices of AppNL-G-F/NL-G-F mice at 2, 4, and 8 months of age using RT-qPCR. This evidence concerns the gene CNR2 and Alzheimer disease.